Key facts
- Neko Health’s last known valuation is $1.8B (Jan 2025).
- It has raised $350.3M; the latest was Later Stage VC ($260.0M) in Jan 2025.
- Notable investors include General Catalyst, Lightspeed Venture Partners, Atomico, Lakestar, O.G. Venture Partners — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Neko Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Neko Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Neko Health
Developer of a medical scanning technology designed to help people stay healthy through preventive measures and early detection. The company leverages sensor technology and artificial intelligence to design medical healthcare that offers early disease prevention while reducing the prevalence of common diseases and their associated costs, enabling doctors and clinicians to offer cheap and flexible examinations that can raise the quality of healthcare and focus on prevention.
- Sector
- Healthcare
- HQ
- Stockholm, Sweden
- Founded
- 2018
- Employees
- 500
- Website
- nekohealth.com/
- Ownership
- Privately Held (backing)
Neko Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Neko Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Neko Health in its N-PORT filings yet. We sweep new filings monthly.